NCT01374711 The Effects of Immunostimulation With GM-CSF or IFN-y on Immunoparalysis Following Human Endotoxemia Status COMPLETED Phase NA
NCT01322490 A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer Status COMPLETED Phase PHASE3
NCT01266083 WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase PHASE2
NCT01265901 IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma Status COMPLETED Phase PHASE3
NCT01174082 Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant Status TERMINATED Phase PHASE2
NCT01064375 Safety Study of DNA Vaccine Delivered by Intradermal Electroporation to Treat Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00952237 Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF Status COMPLETED Phase PHASE1
NCT00948480 Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic Cells Status COMPLETED Phase PHASE2
NCT00880243 Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE3
NCT00799110 Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00769704 Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma Status COMPLETED Phase PHASE3
NCT00678054 Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA) Status COMPLETED Phase PHASE2
NCT00661622 Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF Status COMPLETED Phase PHASE2
NCT00631072 In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer Status COMPLETED Phase PHASE1
NCT00616564 Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma Status COMPLETED Phase PHASE2
NCT00600002 Administration as a Biological Adjuvant in Clinically-Staged, Resectable Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1
NCT00548847 Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation Status COMPLETED Phase PHASE2